Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O M Colvin

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Blood|May 15, 1995
Assessment of aldehyde dehydrogenase in viable cellsR J Jones, J P Barber, M S Vala, et al.
Neurosurgery|February 1, 1990
L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic miceB E Lippitz, E C Halperin, O W Griffith, et al.
Medical and Pediatric Oncology|September 1, 1995
Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastomaA Moghrabi, H Fuchs, M Brown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationL B Grochow, R J Jones, R B Brundrett, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agentsC A Coggins, G B Elion, P J Houghton, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumorsM L Hanley, G B Elion, O M Colvin, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamideJ L Flowers, S M Ludeman, M P Gamcsik, et al.
Medical and Pediatric Oncology|April 1, 1995
Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasmsD H Lachance, D Oette, S C Schold, et al.
Journal of Clinical Pharmacology|August 1, 1981
Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicinC E Riggs, M J Egorin, J Z Fuks, et al.
Journal of Medicinal Chemistry|March 4, 1998
The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactionsE M Shulman-Roskes, D A Noe, M P Gamcsik, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Blood|May 15, 1995
Assessment of aldehyde dehydrogenase in viable cellsR J Jones, J P Barber, M S Vala, et al.
Neurosurgery|February 1, 1990
L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic miceB E Lippitz, E C Halperin, O W Griffith, et al.
Medical and Pediatric Oncology|September 1, 1995
Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastomaA Moghrabi, H Fuchs, M Brown, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationL B Grochow, R J Jones, R B Brundrett, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agentsC A Coggins, G B Elion, P J Houghton, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumorsM L Hanley, G B Elion, O M Colvin, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamideJ L Flowers, S M Ludeman, M P Gamcsik, et al.
Medical and Pediatric Oncology|April 1, 1995
Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasmsD H Lachance, D Oette, S C Schold, et al.
Journal of Clinical Pharmacology|August 1, 1981
Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicinC E Riggs, M J Egorin, J Z Fuks, et al.
Journal of Medicinal Chemistry|March 4, 1998
The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactionsE M Shulman-Roskes, D A Noe, M P Gamcsik, et al.
Pageof 13